These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33839684)

  • 1. The STAT3 inhibitor Stattic acts independently of STAT3 to decrease histone acetylation and modulate gene expression.
    Poria DK; Sheshadri N; Balamurugan K; Sharan S; Sterneck E
    J Biol Chem; 2021; 296():100220. PubMed ID: 33839684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma.
    Pan Y; Zhou F; Zhang R; Claret FX
    PLoS One; 2013; 8(1):e54565. PubMed ID: 23382914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.
    Wang H; Tao Z; Feng M; Li X; Deng Z; Zhao G; Yin H; Pan T; Chen G; Feng Z; Li Y; Zhou Y
    Biochem Biophys Res Commun; 2020 Dec; 533(3):368-375. PubMed ID: 32962858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stattic sensitizes osteosarcoma cells to epidermal growth factor receptor inhibitors via blocking the interleukin 6-induced STAT3 pathway.
    Wang S; Wang Y; Huang Z; Wei H; Wang X; Shen R; Lan W; Zhong G; Lin J
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1670-1680. PubMed ID: 34693451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Acetyl cysteine prevents activities of STAT3 inhibitors, Stattic and BP-1-102 independently of its antioxidant properties.
    Uchihara Y; Ohe T; Mashino T; Kidokoro T; Tago K; Tamura H; Funakoshi-Tago M
    Pharmacol Rep; 2019 Dec; 71(6):1067-1078. PubMed ID: 31627175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stattic inhibits RANKL-mediated osteoclastogenesis by suppressing activation of STAT3 and NF-κB pathways.
    Li CH; Xu LL; Jian LL; Yu RH; Zhao JX; Sun L; Du GH; Liu XY
    Int Immunopharmacol; 2018 May; 58():136-144. PubMed ID: 29587202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer.
    Han Z; Wang X; Ma L; Chen L; Xiao M; Huang L; Cao Y; Bai J; Ma D; Zhou J; Hong Z
    Oncotarget; 2014 Sep; 5(18):8416-28. PubMed ID: 25261365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma.
    Zhang Q; Zhang C; He J; Guo Q; Hu D; Yang X; Wang J; Kang Y; She R; Wang Z; Li D; Huang G; Ma Z; Mao W; Zhou X; Xiao C; Sun X; Ma J
    Tumour Biol; 2015 Mar; 36(3):2135-42. PubMed ID: 25492480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells.
    Jafari S; Lavasanifar A; Hejazi MS; Maleki-Dizaji N; Mesgari M; Molavi O
    Daru; 2020 Jun; 28(1):159-169. PubMed ID: 31942696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects.
    Li M; Xie Y; Zhang J; Zhou X; Gao L; He M; Liu X; Miao X; Liu Y; Cao R; Jia Y; Zeng Z; Liu L
    Cancer Lett; 2024 Aug; 598():217111. PubMed ID: 38972347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells.
    Moon SY; Lee H; Kim S; Hong JH; Chun SH; Lee HY; Kang K; Kim HS; Won HS; Ko YH
    BMC Cancer; 2021 Aug; 21(1):931. PubMed ID: 34407787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stattic Enhances Radiosensitivity and Reduces Radio-Induced Migration and Invasion in HCC Cell Lines through an Apoptosis Pathway.
    Xu G; Zhu L; Wang Y; Shi Y; Gong A; Wu C
    Biomed Res Int; 2017; 2017():1832494. PubMed ID: 29226125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization.
    Schust J; Sperl B; Hollis A; Mayer TU; Berg T
    Chem Biol; 2006 Nov; 13(11):1235-42. PubMed ID: 17114005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
    Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
    Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells.
    Oh ET; Park MT; Choi BH; Ro S; Choi EK; Jeong SY; Park HJ
    Invest New Drugs; 2012 Apr; 30(2):435-42. PubMed ID: 20978925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinatory effects of vaccinia virus VG9 and the STAT3 inhibitor Stattic on cancer therapy.
    Yang R; Wang L; Sheng J; Huang Q; Pan D; Xu Y; Yan J; Wang X; Dong Z; Yang M
    Arch Virol; 2019 Jul; 164(7):1805-1814. PubMed ID: 31087190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PERK signaling through C/EBPδ contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells.
    Sheshadri N; Poria DK; Sharan S; Hu Y; Yan C; Koparde VN; Balamurugan K; Sterneck E
    Cell Death Dis; 2021 Nov; 12(11):1038. PubMed ID: 34725321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits.
    Chung SS; Giehl N; Wu Y; Vadgama JV
    Int J Oncol; 2014 Feb; 44(2):403-11. PubMed ID: 24297508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-κB/STAT3 complex to its promoter in malignant lymphoid cells.
    Scuto A; Kirschbaum M; Buettner R; Kujawski M; Cermak JM; Atadja P; Jove R
    Cell Death Dis; 2013 May; 4(5):e635. PubMed ID: 23681230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.